About the Inner Ear Disorders Therapeutics Summit 2023
Attendees got the opportunity to learn about the latest advancements in protection, enhancement and regeneration to treat hearing loss through the lens of different modalities including gene therapy, small molecule and stem cell therapy approaches. They also learned how to deliver therapies to relevant inner ear cells effectively, extrapolate clinically relevant information from preclinical models, explore how combination therapies could maximize efficacy, and learn from high-profile failures to avoid pitfalls in their own development.
Join Your Peers to:
Explored how to improve clinical trial design to increase the number of clinical trials achieving regulatory approval with former Frequency and Otonomy employees along with Astellas, AudioCure Pharma and Oricular Therapeutics
Delved into the numerous delivery methods being employed in industry and explore how to optimize delivery to the inner ear with important updates from Sensorion, Akouos, Spiral Therapeutics and more
Evaluated the current opportunities and limitations of using animal models to accurately predict preclinical efficacy and translational success with an interactive panel discussion and key insights from Acousia Therapeutics and Oricular Therapeutics
Leveraged valuable insights from VC investors to understand the key considerations made when investing in or forging partnerships with biotechs focussing on inner ear disorder therapeutics
Navigated the complex landscape of improving the diagnostics of inner ear disorders by developing a robust diagnostic toolbox and strategizing how to supplement patient-reported outcome measures including objective pharmacodynamic measurements with Cincinnati Children's Hospital
Who Attended in 2023?
Join your peers working in preclinical and clinical development, pharmaceutical research and translational research at the only industry focussed meeting on overcoming the challenges related to optimizing inner ear disorders therapeutics.
